cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Terns Pharmaceuticals Inc
8 own
6 watching
Current Price
$4.56
$-0.03
(-0.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
427.56M
52-Week High
52-Week High
14.04400
52-Week Low
52-Week Low
3.26000
Average Volume
Average Volume
0.83M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization427.56M
icon52-Week High14.04400
icon52-Week Low3.26000
iconAverage Volume0.83M
iconDividend Yield--
iconP/E Ratio--
What does the Terns Pharmaceuticals Inc do?
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Read More
How much money does Terns Pharmaceuticals Inc make?
News & Events about Terns Pharmaceuticals Inc.
Zolmax
1 year ago
Terns Pharmaceuticals (NASDAQ:TERN Get Rating) had its target price increased by JPMorgan Chase & Co. from $6.00 to $9.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. Several other analysts have also recently commented on the stock. The ...
Ticker Report
1 year ago
Terns Pharmaceuticals (NASDAQ:TERN Get Rating) and Phibro Animal Health (NASDAQ:PAHC Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings...
Globe Newswire
1 year ago
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in OncologyFOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-...
Zolmax
1 year ago
UBS Group assumed coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN Get Rating) in a research note published on Tuesday , Marketbeat.com reports. The brokerage issued a buy rating and a $19.00 target price on the stock. A number of other research analysts have also recently issued reports on ...
Globe Newswire
1 year ago
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic ...
Frequently Asked Questions
Frequently Asked Questions
What is Terns Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Terns Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Terns Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Terns Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Terns Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Terns Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Terns Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Terns Pharmaceuticals Inc?
plus_minus_icon
What percentage is Terns Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Terns Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.56
$-0.03
(-0.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00